Delivery Order SPE2DR25D1202-SPE2DR26F74BG
- Not listed
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,652.23 to Amerisourcebergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract carries a firm fixed-price structure with an ultimate completion date of January 12, 2026, and was awarded on a competitive, non-set-aside basis. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical...
- On January 9, 2026, the Defense Logistics Agency awarded a $37,342.01 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with performance through January 12, 2026. The contract utilizes firm fixed-price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. (doing business as AmerisourceBergen)...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $11,576.96 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This firm fixed-price delivery order, which is not set aside for any specific business category, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. The award represents a small task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,623.31 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $33,915.03 to Amerisourcebergen Drug Corp for the supply of Repatha 140 mg/ml SureClick autoinjectors. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 8, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under DLA's larger Indefinite Delivery Contract (IDC) with Cencora, Inc....
- The Defense Logistics Agency awarded a $38,297.64 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 19, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania headquarters. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,176.37 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $6,948.71 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 5, 2025. This non-competitive, firm fixed-price delivery order was issued on November 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA's Medical...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74BGDelivery Order
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $32,118.24 to Amerisourcebergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and represents a non-set-aside competitive award. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The awardee operates as a subsidiary of Cencora, Inc., which does business as Amerisourcebergen. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Repatha is a prescription medication used for cholesterol management, and this particular task order fulfills DLA's requirements for supply to federal medical facilities and military treatment facilities that support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.1k | 1/14/26 |